Results 111 to 120 of about 432,030 (193)

Medications for Alcohol Use Disorder Among Patients With Severe Alcohol-Related Liver Disease. [PDF]

JAMA Netw Open
Sundaresh R, Singh J, Meza J, Saab S, Shetty A.   +4 more
europepmc   +1 more source

Non-invasive tests for MetALD and alcohol-related liver disease. [PDF]

JHEP Rep
Johansen S, Thiele M, Krag A.
europepmc   +1 more source

Distinct Laboratory and Clinical Features of Metabolic and Alcohol-Related Liver Disease (MetALD): A Systematic Review and Meta-Analysis. [PDF]

Curr Obes Rep
Tampaki M, Lekakis V, Chologkitas C, Polyzos SΑ, Cholongitas E.   +4 more
europepmc   +1 more source

Educational disparities in alcohol-related liver disease mortality in the 21st century: Beyond deaths of despair? [PDF]

Alcohol Clin Exp Res (Hoboken)
Grucza RA, Hwang JJ, Scherrer JF, Bello JK, Gebauer SC, Huang R, Salas J, Xu KY.   +7 more
europepmc   +1 more source

Fibrosis activity <i>vs</i>. disease stage: Complementary and independent predictors of outcomes in alcohol-related liver disease. [PDF]

JHEP Rep
Johansen S, Israelsen M, Thorhauge KH, Hansen JK, Hansen CD, Schnefeld HL, Andersen P, Villesen I, Bech KT, Detlefsen S, Torp N, Leeming D, Thiele M, Krag A, Karsdal M, GALAXY consortia.   +15 more
europepmc   +1 more source

Alcohol‐related liver disease treatment and EBM

Liver International, 2022
Braillon, Alain, Naudet, Florian
openaire   +3 more sources

Alcohol-Related Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease: Molecular Pathogenesis and Therapeutic Interventions. [PDF]

MedComm (2020)
Tan Y, Hu Y, Yang Y, Chu H.
europepmc   +1 more source

Burden of Alcohol-Related Liver Disease and Alcohol Use Disorder in Asia. [PDF]

United European Gastroenterol J
Danpanichkul P, Pang Y, Suparan K, Saokhieo P, Jatupornpakdee P, Polpichai N, Attachaipanich T, Suenghataiphorn T, Ibrahim AF, Vichitkunakorn P, Chirapongsathorn S, Choudhury A, Kulkarni AV, Wijarnpreecha K, Kaewdech A, Liangpunsakul S.   +15 more
europepmc   +1 more source

Compositional and Metabolomic Shifts of the Gut Microbiome in Alcohol-Related Liver Disease. [PDF]

J Gastroenterol Hepatol
Kuo CH, El-Omar E, Kao CY, Lin JT, Wu CY.   +4 more
europepmc   +1 more source

Goblet-cell muscarinic signaling at the gut barrier: A therapeutic checkpoint/target in alcohol-related liver disease. [PDF]

JHEP Rep
Piano S, Bezzegato G, Albillos A.
europepmc   +1 more source